BlackRock’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Buy
6,303,433
+2,997,859
+91% +$5.32M ﹤0.01% 3471
2025
Q4
$6.78M Buy
3,305,574
+230,388
+7% +$367K ﹤0.01% 3698
2025
Q3
$4.98M Buy
3,075,186
+347,018
+13% +$601K ﹤0.01% 3786
2025
Q2
$5.32M Buy
2,728,168
+2,304,189
+543% +$4.51M ﹤0.01% 3744
2025
Q1
$929K Buy
423,979
+88,519
+26% +$222K ﹤0.01% 4213
2024
Q4
$1.09M Buy
+335,460
New +$837K ﹤0.01% 4202
2022
Q2
Sell
-8,583
Closed -$76K 5912
2022
Q1
$76K Sell
8,583
-424
-5% -$3.41K ﹤0.01% 5342
2021
Q4
$79K Buy
9,007
+550
+7% +$6.07K ﹤0.01% 5327
2021
Q3
$96K Buy
8,457
+6,195
+274% +$83.8K ﹤0.01% 5146
2021
Q2
$38K Buy
2,262
+2,167
+2,281% +$63.8K ﹤0.01% 5223
2021
Q1
$3K Buy
+95
New +$3.85K ﹤0.01% 5179

Other funds holding IKT